The Jungle, War Wounds and Psychedelic Therapy

September 4, 2020 14:34:05

As many soldiers return home with their souls in pieces and having no sense of self, many decline to use anti-depressants because of the many effects they have and instead, choose to imbibe and drown themselves in liquor, hoping to numb the pain without getting to the root cause and dealing with it in order to begin the healing process.

However, in Western Costa Rica, psychedelic-assisted healing retreats such as the Soltara Healing Center, provide an alternative solution to antidepressants as well as other commonly prescribed pharmaceuticals with the use of ayahuasca, a hallucinogenic brew. Indigenous communities of the Amazonian forest have used this brew for centuries, and contains DMT, a hallucinogen. Some regard it as a powerful medicine that keeps them spiritually strong and in harmony with the natural world.

The psychedelic brew can be used in ceremonial settings as its considered legal in Latin American countries. These ceremonies, which are usually emotionally and physically draining, but can, in a controlled environment, help an individual with repressed trauma work through their trauma as well as help give rise to new insights.

However, it should be noted that drinking ayahuasca while on antidepressants is detrimental and its use can also lead to psychotic episodes, especially for people who suffer from mental health conditions such as schizophrenia. Also, some people have reported feeling worse emotionally, mentally and physically after a psychedelic trip.

Dr. Johnson from Johns Hopkins University as well as other experts are also skeptical of psychedelics use in retreats as well as other settings without appropriate control. The lack of a well-equipped medical support team is an added disadvantage, for the uncommon instances when people react adversely to these psychedelics.

All in all, the benefits outweigh the risks and this only goes to show that the therapeutic possibilities that psychedelics offer all without the side effects that antidepressants have on their users. Psychedelics are noted to, instead of numbing their users, advance the psychotherapy healing process. Many soldiers who visited these retreats have reported to feeling hopeful again, renewed and with a new sense of purpose. Some even reported that they had no more suicidal thoughts or depressive episodes.

In addition, the FDA designating MDMA and psilocybin as breakthrough therapies also adds to the potential that psychedelics could have in the years to come as medicines and alternatives to other pharmaceutical drugs for various mental disorders.

Additionally, ayahuasca centers that are responsibly and well run, with the inclusion of medical professions might be the dawn of a new age in therapy using psychedelics to treat mental health conditions and offer mental health care.

With the many benefits that ayahuasca offers to people who are suffering from trauma, post-traumatic stress disorder, depression as well as suicidal thoughts, it seems the additional testimonies to the decriminalization of psychedelics movement just might help tip the scale in its favor and further the research into the potential of the use of different psychedelic substances.

Analysts say entities like Cybin Corp. are counting on this growing support to carry them forward in the coming decades.

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.